{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T03:25:04Z","timestamp":1787714704509,"version":"build-2784847793"},"reference-count":98,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2023,11,2]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>This study aims to characterise the symptoms and clinical features of optic neuritis (ON) following SARS-CoV-2 infection and vaccination.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>A literature search was conducted in four databases (PubMed, Medline, Embase and Google Scholar) to identify relevant case reports and case series. The records were screened and articles adhering to the inclusion criteria were critically appraised.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Sixty-eight studies were found to be eligible for inclusion, including 34 reporting ON following SARS-CoV-2 infection and an equal number reporting cases postvaccination. In total 93 patients and 125 eyes were included. The infection cohort included 42 patients and 56 eyes, 51.2% were female and 33.3% experienced bilateral ON. The mean visual acuity was 1.64 log of minimum angle of resolution (LogMAR), while pain was present in 77.8%. Oligoclonal bands were present in 3 patients, myelin oligodendrocyte glycoprotein (MOG) antibodies in 18 patients and AQP-4 antibodies in 4 patients. The vaccination cohort included 51 patients and 69 eyes. 60.8% were female and 35.3% had a bilateral ON. The mean visual acuity was 0.93 LogMAR. Oligoclonal bands were present in 46.7%, MOG antibodies in nine patients and AQP-4 antibodies in three patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Patients with ON post-SARS-CoV infection were more likely to experience severe visual impairment than in cases following vaccination. Further research is required to outline the clinical features of ON after COVID-19 infection and vaccination, and establish causality.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjophth-2023-001336","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T21:30:35Z","timestamp":1701898235000},"page":"e001336","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Systematic review exploring the clinical features of optic neuritis after SARS-CoV infection and vaccination"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6410-3939","authenticated-orcid":false,"given":"Iliana","family":"Georganta","sequence":"first","affiliation":[{"name":"Royal Infirmary of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Chasapi","sequence":"additional","affiliation":[{"name":"Royal Infirmary of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Jayne","family":"Smith","sequence":"additional","affiliation":[{"name":"Royal Infirmary of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kopsidas","sequence":"additional","affiliation":[{"name":"Head and Neck Eye Clinic, Peterborough City Hospital, Peterborough, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0372-3100","authenticated-orcid":false,"given":"Andrew","family":"Tatham","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Princess Alexandra Eye Pavilion, Edinburgh, UK"},{"name":"Center for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"key":"2025090109594582000_8.1.e001336.1","doi-asserted-by":"crossref","unstructured":"Khairallah M , Kahloun R , Abroug N , et al . n.d. Infectious optic Neuropathies: a clinical update. EB:59. doi:10.2147\/EB.S69173","DOI":"10.2147\/EB.S69173"},{"key":"2025090109594582000_8.1.e001336.2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0049475519872370","article-title":"Et.Al.optic neuritis following anti-Rabies vaccine","volume":"50","author":"Agarwal","year":"2020","journal-title":"Trop Doct"},{"key":"2025090109594582000_8.1.e001336.3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/01658107.2017.1335333","article-title":"Atypical optic neuritis after Inactivated influenza vaccination","volume":"42","author":"Jun","year":"2018","journal-title":"Neuroophthalmology"},{"key":"2025090109594582000_8.1.e001336.4","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_297_21"},{"key":"2025090109594582000_8.1.e001336.5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10072-021-05662-9","article-title":"Spectrum of neurological complications following COVID-19 vaccination","volume":"43","author":"Garg","year":"2022","journal-title":"Neurol Sci"},{"key":"2025090109594582000_8.1.e001336.6","doi-asserted-by":"crossref","unstructured":"Rom\u00e1n GC , Gracia F , Torres A , et al . Acute transverse Myelitis (ATM):Clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the Chadox1 nCoV-19 vaccine (Azd1222). Front Immunol 2021;12. doi:10.3389\/fimmu.2021.653786","DOI":"10.3389\/fimmu.2021.653786"},{"key":"2025090109594582000_8.1.e001336.7","doi-asserted-by":"crossref","unstructured":"Ouzzani M , Hammady H , Fedorowicz Z , et al . Zbys Fedorowicz Et.Al. Rayyan \u2014 a web and mobile App for systematic reviews. Syst Rev 2016;5. doi:10.1186\/s13643-016-0384-4","DOI":"10.1186\/s13643-016-0384-4"},{"key":"2025090109594582000_8.1.e001336.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01283-z"},{"key":"2025090109594582000_8.1.e001336.9","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.6.658"},{"key":"2025090109594582000_8.1.e001336.10","unstructured":"WHO Programme for the Prevention of Blindness and Deafness . Consultation on development of standards for characterization of vision loss and visual functioning: Genveva, 4-5 September 2003. World Health Organization, 2003."},{"key":"2025090109594582000_8.1.e001336.11","unstructured":"Microsoft Corporation . Microsoft excel. 2018. Available: https:\/\/office.microsoft.com\/excel"},{"key":"2025090109594582000_8.1.e001336.12","article-title":"Optic neuritis in a child with COVID-19: A rare Association","volume":"13","author":"Parvez","year":"2021","journal-title":"Cureus"},{"key":"2025090109594582000_8.1.e001336.13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/cjn.2021.183","article-title":"Optic neuritis associated with SARS-Cov-2 B.1.1.7 variant of concern","volume":"49","author":"Micieli","year":"2022","journal-title":"Can J Neurol Sci"},{"key":"2025090109594582000_8.1.e001336.14","doi-asserted-by":"crossref","first-page":"e571","DOI":"10.1097\/WNO.0000000000001347","article-title":"Antiaquaporin 4-related optic neuritis and Myelitis post-COVID-19 infection","volume":"42","author":"Kivanany","year":"2022","journal-title":"J Neuroophthalmol"},{"key":"2025090109594582000_8.1.e001336.15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577933","article-title":"Myelin Oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-Cov-2 infection: A case series","volume":"370","author":"Lambe","year":"2022","journal-title":"J Neuroimmunol"},{"key":"2025090109594582000_8.1.e001336.16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s13365-020-00934-0","article-title":"Magnetic resonance imaging features of COVID-19-related cranial nerve lesions","volume":"27","author":"Corr\u00eaa","year":"2021","journal-title":"J Neurovirol"},{"key":"2025090109594582000_8.1.e001336.17","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2020.0555"},{"key":"2025090109594582000_8.1.e001336.18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4103\/ijo.IJO_3666_20","article-title":"Shirodkar R, Et.Al.unilateral inferior Altitudinal visual field defect related to COVID-19","volume":"69","author":"Sharma","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"2025090109594582000_8.1.e001336.19","doi-asserted-by":"crossref","unstructured":"Kogure C , Kikushima W , Fukuda Y , et al . n.d. Myelin Oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: A case report. Medicine;100:e25865. doi:10.1097\/MD.0000000000025865","DOI":"10.1097\/MD.0000000000025865"},{"key":"2025090109594582000_8.1.e001336.20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajoc.2022.101273","article-title":"Bilateral optic neuritis as the presenting sign of post SARS-Cov-2 acute disseminated Encephalomyelitis","volume":"25","author":"Rossi","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"2025090109594582000_8.1.e001336.21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1055\/a-1771-6519","article-title":"Unilateral optic neuritis as the first and only manifestation of SARS-Cov-2 infection","volume":"239","author":"Giacuzzo","year":"2022","journal-title":"Klin Monbl Augenheilkd"},{"key":"2025090109594582000_8.1.e001336.22","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2169\/internalmedicine.8709-21","article-title":"SARS-Cov-2-related myelin Oligodendrocyte glycoprotein antibody-associated disease: A case report and literature review","volume":"61","author":"Ide","year":"2022","journal-title":"Intern Med"},{"key":"2025090109594582000_8.1.e001336.23","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s12098-020-03656-7","article-title":"Myelin Oligodendrocyte glycoprotein (MOG) antibody disease in a 11 year old with COVID-19 infection","volume":"88","author":"Khan","year":"2021","journal-title":"Indian J Pediatr"},{"key":"2025090109594582000_8.1.e001336.24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/ncn3.12595","article-title":"Myelin-Oligodendrocyte glycoprotein antibody-associated optic neuritis following SARS-Cov-2 pneumonia: A case report","volume":"10","author":"Mitarnun","year":"2022","journal-title":"Neurol Clin Neurosci"},{"key":"2025090109594582000_8.1.e001336.25","doi-asserted-by":"publisher","DOI":"10.1097\/wno.0000000000001049"},{"key":"2025090109594582000_8.1.e001336.26","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1004132","article-title":"Double Seropositive Neuromyelitis Optica associated with COVID-19: A case report","volume":"13","author":"Antonescu Ghelmez","year":"2022","journal-title":"Front Neurol"},{"key":"2025090109594582000_8.1.e001336.27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/11206721221136319","article-title":"MOG-IgG positive optic neuritis after SARS-Cov-2 infection","volume":"33","author":"Gilardi","year":"2023","journal-title":"Eur J Ophthalmol"},{"key":"2025090109594582000_8.1.e001336.28","article-title":"COVID-19 associated optic neuritis","volume":"63","author":"Sangal","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2025090109594582000_8.1.e001336.29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2022.100411","article-title":"Abrupt bilateral blindness as a rare post-acute Demyelinating consequence of COVID-19","volume":"28","author":"Motahharynia","year":"2022","journal-title":"eNeurologicalSci"},{"key":"2025090109594582000_8.1.e001336.30","unstructured":"Anton . n.d. 15th EUNOS Congress, Suppl 1-139. Neuro-Ophthalmology;46. doi:10.1080\/10.1080\/01658107.2022.206418801658107.2022.2064188"},{"key":"2025090109594582000_8.1.e001336.31","doi-asserted-by":"crossref","unstructured":"Eslamiyeh H , Jafari M . Binocular optic neuritis in an eight-year-old boy due to COVID-19 infection. Iran J Pediatr 2021;31. doi:10.5812\/ijp.111798 Available: https:\/\/doi.org\/10.5812\/ijp.111798","DOI":"10.5812\/ijp.111798"},{"key":"2025090109594582000_8.1.e001336.32","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jfo.2021.04.002","article-title":"Optic neuropathy in a COVID-19 patient","volume":"44","author":"Borrego-Sanz","year":"2021","journal-title":"J Fr Ophtalmol"},{"key":"2025090109594582000_8.1.e001336.33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajoc.2022.101491","article-title":"Myelin Oligodendrocyte glycoprotein antibody-associated optic neuritis with COVID-19 infection: A case report and literature review","volume":"26","author":"Assavapongpaiboon","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"2025090109594582000_8.1.e001336.34","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/ijo.IJO_2235_21","article-title":"COVID-19-associated optic neuritis - A case series and review of literature","volume":"70","author":"Jossy","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"2025090109594582000_8.1.e001336.35","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.4103\/ijo.IJO_2155_21","article-title":"Acute bilateral retrobulbar optic neuritis - an atypical Sequela of COVID-19","volume":"69","author":"Sainath","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"2025090109594582000_8.1.e001336.36","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.931665","article-title":"Unilateral optic neuritis associated with SARS-Cov-2 infection: A rare complication","volume":"22","author":"Deane","year":"2021","journal-title":"Am J Case Rep"},{"key":"2025090109594582000_8.1.e001336.37","article-title":"Unilateral optic neuritis in post COVID-19: A case report","volume":"15","author":"Ahmed","year":"2021","journal-title":"JCDR"},{"key":"2025090109594582000_8.1.e001336.38","doi-asserted-by":"crossref","first-page":"101320","DOI":"10.1016\/j.inat.2021.101320","article-title":"Optic neuritis post-COVID-19 infection. A case report with meta-analysis","volume":"26","author":"Azab","year":"2021","journal-title":"Interdiscip Neurosurg"},{"key":"2025090109594582000_8.1.e001336.39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s13365-021-00959-z","article-title":"Optic neuritis following SARS-Cov-2 infection","volume":"27","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2021","journal-title":"J Neurovirol"},{"key":"2025090109594582000_8.1.e001336.40","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinph.2021.11.042","article-title":"Hp47: post Covid optic neuritis,Egyptian two case reports","volume":"135","author":"Hussein","year":"2022","journal-title":"Clinical Neurophysiology"},{"key":"2025090109594582000_8.1.e001336.41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.118462","article-title":"Nurhan Kaya Tutar, et.Al.vision loss related to COVID-19 infection: A case series of atypical optic neuritis","volume":"429","author":"Kale","year":"2021","journal-title":"Journal of the Neurological Sciences"},{"key":"2025090109594582000_8.1.e001336.42","doi-asserted-by":"crossref","DOI":"10.1177\/2324709620976018","article-title":"COVID-19-induced acute bilateral optic neuritis","volume":"8","author":"Sawalha","year":"2020","journal-title":"J Investig Med High Impact Case Rep"},{"key":"2025090109594582000_8.1.e001336.43","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000797","article-title":"Acute disseminated Encephalomyelitis after SARS-Cov-2 infection","volume":"7","author":"Novi","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025090109594582000_8.1.e001336.44","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/acn3.51609","article-title":"SARS-COV-2 a trigger of myelin Oligodendrocyte glycoprotein-associated disorder","volume":"9","author":"Johnsson","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"2025090109594582000_8.1.e001336.45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jpeds.2022.05.018","article-title":"Neuroinflammatory disease following severe acute respiratory syndrome Coronavirus 2 infection in children","volume":"247","author":"Aubart","year":"2022","journal-title":"J Pediatr"},{"key":"2025090109594582000_8.1.e001336.46","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00415-021-10780-7","article-title":"COVID-19 mRNA vaccination leading to CNS inflammation: a case series","volume":"269","author":"Khayat-Khoei","year":"2022","journal-title":"J Neurol"},{"key":"2025090109594582000_8.1.e001336.47","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/00207454.2021.2015348","article-title":"Et.Al.optic neuropathy after COVID-19 vaccination: a report of two cases","volume":"133","author":"Elnahry","year":"2023","journal-title":"Int J Neurosci"},{"key":"2025090109594582000_8.1.e001336.48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/NDT.S343438","article-title":"Post COVID-19 vaccination-associated neurological complications","volume":"Volume 18","author":"Assiri","year":"2022","journal-title":"NDT"},{"key":"2025090109594582000_8.1.e001336.49","doi-asserted-by":"publisher","DOI":"10.1111\/cen3.12682"},{"key":"2025090109594582000_8.1.e001336.50","article-title":"Myelin Oligodendrocyte glycoprotein-associated disorders post-Chadox1 vaccination","volume":"14","author":"Maramattom","year":"2022","journal-title":"Cureus"},{"key":"2025090109594582000_8.1.e001336.51","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1007\/s10072-021-05832-9","article-title":"Et.Al.bilateral optic neuritis after COVID vaccination","volume":"43","author":"Arnao","year":"2022","journal-title":"Neurol Sci"},{"key":"2025090109594582000_8.1.e001336.52","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031112","article-title":"Silent progressive bilateral Papillitis after COVID-19 vaccination: A case report","volume":"101","author":"Lee","year":"2022","journal-title":"Medicine"},{"key":"2025090109594582000_8.1.e001336.53","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1080\/09273948.2022.2137044","article-title":"Bilateral atypical optic neuritis following Chadox1_Ncov-19 vaccination: A putative Plausibility","volume":"31","author":"Saluja","year":"2023","journal-title":"Ocular Immunology and Inflammation"},{"key":"2025090109594582000_8.1.e001336.54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10633-022-09880-0","article-title":"Unilateral optic neuritis after vaccination against the Coronavirus disease: two case reports","volume":"145","author":"Wang","year":"2022","journal-title":"Doc Ophthalmol"},{"key":"2025090109594582000_8.1.e001336.55","doi-asserted-by":"crossref","first-page":"679","DOI":"10.4103\/ijo.IJO_2374_21","article-title":"Et.Al.optic neuritis following COVID-19 vaccination: coincidence or side-effect? - A case series","volume":"70","author":"Roy","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"2025090109594582000_8.1.e001336.56","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10101574","article-title":"A case of atypical unilateral optic neuritis following BNT162b2 mRNA COVID-19 vaccination","volume":"10","author":"Motegi","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2025090109594582000_8.1.e001336.57","doi-asserted-by":"crossref","unstructured":"Donaldson LC , Margolin EA . Myelin Oligodendrocyte glycoprotein antibody-mediated optic neuritis following COVID-19 vaccination. J Neuroophthalmol 2022;Publish Ahead of Print. doi:10.1097\/WNO.0000000000001482","DOI":"10.1097\/WNO.0000000000001482"},{"key":"2025090109594582000_8.1.e001336.58","doi-asserted-by":"crossref","unstructured":"Nagaratnam SA , Ferdi AC , Leaney J , et al . Leaney J, Et.Al.acute disseminated Encephalomyelitis with bilateral optic neuritis following Chadox1 COVID-19 vaccination. BMC Neurol 2022;22. doi:10.1186\/s12883-022-02575-8","DOI":"10.1186\/s12883-022-02575-8"},{"key":"2025090109594582000_8.1.e001336.59","doi-asserted-by":"crossref","unstructured":"Tugizova M , Siegel DT , Huang S , et al . Et.Al.case series: atypical optic neuritis after COVID-19 vaccination. J Neuroophthalmol 2022. doi:10.1097\/WNO.0000000000001519","DOI":"10.1097\/WNO.0000000000001519"},{"key":"2025090109594582000_8.1.e001336.60","doi-asserted-by":"crossref","unstructured":"Raxwal T , Akel Z , Naidu J , et al . n.d. Neuro-ophthalmologic symptoms associated with the Moderna mRNA COVID-19 vaccine: A case report. Cureus doi:10.7759\/cureus.28523","DOI":"10.7759\/cureus.28523"},{"key":"2025090109594582000_8.1.e001336.61","doi-asserted-by":"crossref","unstructured":"Saffra NA , Emborgo TS , Kelman SE , et al . Kelman SE, Et.Al.presumed autoimmune optic neuropathy after Pfizer-Biontech (BNT162b2) COVID-19 vaccine. J Neuroophthalmol 2022;Publish Ahead of Print. doi:10.1097\/WNO.0000000000001620","DOI":"10.1097\/WNO.0000000000001620"},{"key":"2025090109594582000_8.1.e001336.62","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/NRL.0000000000000420","article-title":"Afsar N, Et.Al.A case with new-onset Neuromyelitis Optica spectrum disorder following COVID-19 mRNA BNT162b2 vaccination","volume":"27","author":"Caliskan","year":"2022","journal-title":"Neurologist"},{"key":"2025090109594582000_8.1.e001336.63","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11194-9"},{"key":"2025090109594582000_8.1.e001336.64","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/19418744221090426","article-title":"Myelin Oligodendrocyte glycoprotein antibody-associated disease and transverse Myelitis probably associated with SARS-Cov-2 mRNA vaccines: two case reports","volume":"12","author":"Morena","year":"2022","journal-title":"The Neurohospitalist"},{"key":"2025090109594582000_8.1.e001336.65","doi-asserted-by":"crossref","unstructured":"Liu C-C , Lee W-JA . n.d. Bilateral optic neuritis after COVID-19 vaccination: A case report. Vaccines;10:1889. doi:10.3390\/vaccines10111889","DOI":"10.3390\/vaccines10111889"},{"key":"2025090109594582000_8.1.e001336.66","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/qjmed\/hcac208","article-title":"COVID-19 vaccine-associated optic neuritis","volume":"115","author":"Lee","year":"2022","journal-title":"QJM"},{"key":"2025090109594582000_8.1.e001336.67","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.survophthal.2022.09.003","article-title":"Shot in the dark","volume":"68","author":"Bhatti","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"2025090109594582000_8.1.e001336.68","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/11206721221118736","article-title":"Optic neuritis following COVID-19 vaccination: do autoimmune diseases play a role?","volume":"33","author":"Pirani","year":"2023","journal-title":"Eur J Ophthalmol"},{"key":"2025090109594582000_8.1.e001336.69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01658107.2022.2064188","article-title":"15th EUNOS Congress","volume":"46","year":"2022","journal-title":"Neuroophthalmology"},{"key":"2025090109594582000_8.1.e001336.70","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajoc.2022.101592","article-title":"Neuroretinitis after the second injection of a SARS-Cov-2-vaccine: A case report","volume":"27","author":"Lee","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"2025090109594582000_8.1.e001336.71","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/01658107.2022.2048861","article-title":"Guillain-Barr\u00e9 syndrome and unilateral optic neuritis following vaccination for COVID-19: A","volume":"46","author":"Richardson-May","year":"2022","journal-title":"Neuroophthalmology"},{"key":"2025090109594582000_8.1.e001336.72","first-page":"909","article-title":"Neuromyelitisoptica like presentation following COVID vaccination Shaifali Arora, Vineet Sehgal","volume":"8","year":"2021","journal-title":"Priyanshu Bansal European Journal of Molecular & Clinical Medicine"},{"key":"2025090109594582000_8.1.e001336.73","doi-asserted-by":"crossref","first-page":"118186","DOI":"10.1016\/j.jns.2021.118186","article-title":"Inflammatory optic neuropathy following SARS-Cov-2 mRNA vaccine: description of two cases","volume":"429","author":"Barone","year":"2021","journal-title":"Journal of the Neurological Sciences"},{"key":"2025090109594582000_8.1.e001336.74","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/cjn.2021.256","article-title":"Combined central and peripheral Demyelination with anti-Neurofascin155 IgG following COVID-19 vaccination","volume":"50","author":"Matteo","year":"2023","journal-title":"Can J Neurol Sci"},{"key":"2025090109594582000_8.1.e001336.75","first-page":"726","article-title":"Acute Demyelinating events triggered by COVID-19 vaccines: case series palace","volume":"27","author":"Camera","year":"2021","journal-title":"Multiple Sclerosis Journal"},{"key":"2025090109594582000_8.1.e001336.76","doi-asserted-by":"crossref","first-page":"103739","DOI":"10.1016\/j.msard.2022.103739","article-title":"COVID-19 vaccine associated Demyelination & its association with MOG antibody","volume":"60","author":"Netravathi","year":"2022","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"2025090109594582000_8.1.e001336.77","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.4103\/ijo.IJO_2122_21","article-title":"Ophthalmic complications of COVID-19 vaccination","volume":"69","author":"Pawar","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"2025090109594582000_8.1.e001336.78","unstructured":"Ehab H , Marcus C , Shemonti H , et al . Aquaporin-4 IgG Neuromyelitis Optica spectrum disorder onset after COVID-19 vaccination: systematic review. J Neuroimmunol 2022."},{"key":"2025090109594582000_8.1.e001336.79","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.151"},{"key":"2025090109594582000_8.1.e001336.80","doi-asserted-by":"publisher","DOI":"10.1080\/17402520500285247"},{"key":"2025090109594582000_8.1.e001336.81","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200932040-00005"},{"key":"2025090109594582000_8.1.e001336.82","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.autrev.2013.10.003","article-title":"The spectrum of post-vaccination inflammatory CNS Demyelinating syndromes.Autoimmunity reviews","volume":"13","author":"Karussis","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2025090109594582000_8.1.e001336.83","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00415-016-8263-4","article-title":"Vaccines and multiple sclerosis: a systematic review","volume":"264","author":"Mailand","year":"2017","journal-title":"J Neurol"},{"key":"2025090109594582000_8.1.e001336.84","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27214"},{"key":"2025090109594582000_8.1.e001336.85","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.059970"},{"key":"2025090109594582000_8.1.e001336.86","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102513","article-title":"Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysis","volume":"16","author":"Ahmed","year":"2022","journal-title":"Diabetes Metab Syndr"},{"key":"2025090109594582000_8.1.e001336.87","doi-asserted-by":"publisher","DOI":"10.1007\/978-81-322-1777-0_6"},{"key":"2025090109594582000_8.1.e001336.88","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8562805","article-title":"Neuroinvasion and inflammation in viral central nervous system infections","volume":"2016","author":"Dahm","year":"2016","journal-title":"Mediators Inflamm"},{"key":"2025090109594582000_8.1.e001336.89","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1217508110"},{"key":"2025090109594582000_8.1.e001336.90","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/jamaneurol.2020.2065","article-title":"Et.Al.Neuropathogenesis and neurologic manifestations of the Coronaviruses in the age of Coronavirus disease 2019: A review","volume":"77","author":"Zubair","year":"2020","journal-title":"JAMA Neurol"},{"key":"2025090109594582000_8.1.e001336.91","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.19.8913-8921.2000"},{"key":"2025090109594582000_8.1.e001336.92","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202273260901"},{"key":"2025090109594582000_8.1.e001336.93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2012.08.032"},{"key":"2025090109594582000_8.1.e001336.94","first-page":"1385","article-title":"Et.Al.Working group on diagnostic criteria for refractory optic neuritis based on Neuroimmunological perspective","volume":"126","author":"Ishikawa","year":"2019","journal-title":"Epidemiol Clin Character Optic Neuritis Japan Ophthalmol"},{"key":"2025090109594582000_8.1.e001336.95","first-page":"159","article-title":"Clinical profile and Aetiology of optic neuritis in hospital Universiti Sains Malaysia--5 years review","volume":"67","author":"Ismail","year":"2012","journal-title":"Med J Malaysia"},{"key":"2025090109594582000_8.1.e001336.96","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.085399"},{"key":"2025090109594582000_8.1.e001336.97","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"key":"2025090109594582000_8.1.e001336.98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228883","article-title":"Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides","volume":"15","author":"Graner","year":"2020","journal-title":"PLoS One"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2023-001336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T17:00:02Z","timestamp":1756746002000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2023-001336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,6]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/bmjophth-2023-001336"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2023-001336","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}